| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRMD | Common Stock | Purchase | $18,900 | +5,000 | +3.2% | $3.78 | 160,034 | 17 May 2022 | Direct | F1 |
| holding | CRMD | Common Stock | 20,000 | 17 May 2022 | Spouse | F2 | |||||
| holding | CRMD | Common Stock | 10,000 | 17 May 2022 | Spouse as Guardian for Grandchildren | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CRMD | Stock Option (Right to Buy Common Stock) | 20,000 | 17 May 2022 | Common Stock | 20,000 | $4.03 | Direct | F3 | |||||
| holding | CRMD | Stock Option (Right to Buy Common Stock) | 30,000 | 17 May 2022 | Common Stock | 30,000 | $8.32 | Direct | F4 | |||||
| holding | CRMD | Stock Option (Right to Buy Common Stock) | 15,000 | 17 May 2022 | Common Stock | 15,000 | $5.63 | Direct | F5 | |||||
| holding | CRMD | Stock Option (Right to Buy Common Stock) | 15,000 | 17 May 2022 | Common Stock | 15,000 | $8.30 | Direct | F6 | |||||
| holding | CRMD | Stock Option (Right to(Right to Buy Common Stock) | 8,000 | 17 May 2022 | Common Stock | 8,000 | $2.85 | Direct | F7 | |||||
| holding | CRMD | Stock Option (Right to Buy Common Stock) | 8,000 | 17 May 2022 | Common Stock | 8,000 | $11.20 | Direct | F8 | |||||
| holding | CRMD | Stock Option (Right to Buy Common Stock) | 1,000 | 17 May 2022 | Common Stock | 10,000 | $21.40 | Direct | F9 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.77 to $3.79, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. |
| F2 | The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. |
| F3 | These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. |
| F4 | These options were granted on 1/11/2021. These options are fully vested. |
| F5 | These options were granted on 2/25/2020. These options are fully vested. |
| F6 | These options were granted on 1/10/2019. These options are fully vested. |
| F7 | These options were granted on 2/16/2018. These options are fully vested. |
| F8 | These options were granted on 2/21/2017. These options are fully vested. |
| F9 | These options were granted on 4/28/2016. These options are fully vested. |